Kalyan Roy: A New Blood Group System Has Been Discovered
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“A New Blood Group Has Been Discovered – And Only One Person in the World Is Known to Have It.
In a remarkable breakthrough in transfusion medicine, French scientists have identified an ultra-rare blood type linked to a woman from Guadeloupe, a French Caribbean island.
What began as a routine pre-surgical blood test in Paris turned into a scientific mystery that would take years to solve.
The Discovery Journey
- In 2011, laboratory specialists detected an unusual antibody pattern that did not match any known blood group system.
- At that time, available technology could not fully explain the anomaly.
- Years later, with the help of advanced DNA sequencing, researchers finally uncovered the genetic mutation responsible for the unique blood profile.
Official Recognition
The International Society of Blood Transfusion (ISBT) has now officially recognized this discovery as the 48th human blood group system.
The newly identified system is called: PIGZ
It contains a high-frequency antigen named: GWADA
The woman’s rare phenotype is described as: GWADA-negative
Why This Is Extraordinary
So far, only one individual on Earth is known to possess this exact blood type.
This means:
- Standard blood units may be incompatible for transfusion
- Finding a matching donor could be nearly impossible
- In an emergency, she may only be compatible with her own blood
Reports suggest the rare genetic variation was inherited from both parents, making the condition exceptionally uncommon.
French medical biologist Thierry Peyrard, associated with France’s national blood service, has been closely involved in the investigation and characterization of this rare blood group.
Why This Matters to Transfusion Medicine
Many people are familiar with:
- A
- B
- AB
- O
- Rh positive/negative
But human blood is far more complex.
Scientists have identified dozens of lesser-known blood group systems that can significantly impact:
- Transfusion safety
- Compatibility testing
- Pregnancy-related immunohematology
- Rare donor management
Even a single unidentified antibody can become life-threatening during transfusion.
Researchers are now exploring whether more individuals—particularly among populations connected to Guadeloupe—may carry the same rare profile.
Finding even a few compatible donors could make a tremendous difference in:
- Emergency transfusions
- Rare blood registries
- Long-term patient care
This discovery is another reminder that transfusion medicine continues to evolve, revealing just how genetically diverse and biologically fascinating human blood truly is.”
Find more posts featuring Kalyan Roy on Hemostasis Today.
-
Jun 26, 2026, 13:58Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
-
Jun 26, 2026, 13:49Raghavendra Rao: The Surprising Link Between Chronic Venous Insufficiency and Falls
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment
-
Jun 26, 2026, 13:25Ángel Cabrera: Clotting Disorders Behind Heavy Menstrual Bleeding
-
Jun 26, 2026, 13:02Turid Kjellevold: The Critical Role of Timely Hemostasis Testing
-
Jun 26, 2026, 10:59Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
-
Jun 26, 2026, 10:52Chinua Onyebuchi: The Future of Stroke Care in Africa Lies in Strong Health Systems
-
Jun 26, 2026, 10:35Habtamu Milkias Wolde: New Insights into Stroke and Traumatic Brain Injury from Global Burden of Disease Data
-
Jun 26, 2026, 10:19Rytis Masiliūnas: Atrial Fibrillation and Stroke Care Disparities Across the Baltic Region